Last reviewed · How we verify
IMC-1
At a glance
| Generic name | IMC-1 |
|---|---|
| Sponsor | Innovative Med Concepts, LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1 (PHASE2)
- A Study of IMC-1 In Patients With Fibromyalgia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IMC-1 CI brief — competitive landscape report
- IMC-1 updates RSS · CI watch RSS
- Innovative Med Concepts, LLC portfolio CI